NIAID- VRC - PREMISE - Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology

NIAID- VRC - PREMISE - 通过微生物和免疫监测和流行病学的流行病应对存储库

• 批准号: 10710451
• 负责人: CHRISTOPHER CASE
• 金额: $ 100万
• 依托单位: LEIDOS BIOMEDICAL RESEARCH, INC.
• 依托单位国家: 美国
• 财政年份: 2022
• 资助国家: 美国
• 起止时间: 2022-03-04 至 2027-09-15
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10710451
• 关键词: Antigens; Clinic; Communicable Diseases; Detection; Human; Immune; Immune response; Immunologic Epidemiology; Immunologic Surveillance; Laboratories; Mission; Monoclonal Antibodies; National Institute of Allergy and Infectious Disease; Population; Prevention therapy; Translational Research; Virus; cohort; emerging pathogen; microbial; novel strategies; novel therapeutics; pandemic disease; pathogen; prevent; repository; response; therapeutic candidate; vaccine candidate; vaccine discovery

One of the key components of the VRC mission involves the rapid advancement of promising vaccine and therapeutic candidates from the laboratory to the clinic. There is a need for supporting translational research leading to identification of new therapies or approaches in treating and preventing infectious diseases. PREMISE has been developed as a Pandemic Response Repository through Microbial and Immunologic Surveillance and Epidemiology, and provides detection and surveillance of novel and emerging pathogens and deep analysis of host immune responses at a population-wide scale in order to prepare for an effective response to infectious threats.

VRC使命的关键组成部分之一是将有前途的疫苗和治疗候选物从实验室迅速推向临床。有必要支持转化研究，以确定治疗和预防传染病的新疗法或方法。PREMISE已被开发为通过微生物和 免疫监测和流行病学，并提供检测和监测新的和 新兴病原体和深层 在整个人群范围内分析宿主免疫反应，以便为有效应对传染病威胁做好准备。